The Harvey Nash/KPMG CIO Survey is the largest IT leadership study in the world, with almost 4,500 respondents across 86 countries, representing over US $300bn of IT budget spend.
CIOs in pharmaceuticals face three competing barriers in this emerging digital ecosystem: requirements to decrease costs as margins are squeezed; regulatory and legal challenges; and competition from non-traditional healthcare industries who are using strictlydigitally-focused business models. Pharmaceutical companies have been slow to adapt effective digital strategies to support the overall business vision, opening the door for the ones “who get it right” to leapfrog their competition. While CIOs still view themselves as leading innovation from a technical / IT standpoint, many have not moved into supporting enterprise-wide innovation. Pharmaceutical CIOs need to move the needle from a traditional IT operations focus, to enabling innovation by continuing to invest in cloud-based solutions, while leveraging the emergence of disruptive technologies such as Internet of Things, Artificial Intelligence and digital labor.